Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

Background Treatment of systemic lupus erythematosus(SLE) with severe diffuse proliferative nephritisis often challenging, particularly in small children in whom a genetic conditioning is likely to play a role. The effectiveness of standard therapy based on glucocorticoid and immunosuppressive drugsis often unsatisfactory.